Suppr超能文献

噬菌体和生物膜控制中的溶菌素

Bacteriophages and Lysins in Biofilm Control.

机构信息

Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), R. Weigla 12, 53-114, Wrocław, Poland.

Phage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), R. Weigla 12, 53-114, Wrocław, Poland.

出版信息

Virol Sin. 2020 Apr;35(2):125-133. doi: 10.1007/s12250-019-00192-3. Epub 2020 Mar 3.

Abstract

To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized. In vitro, ex vivo and in vivo biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics in vitro or in vivo confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins in vitro, ex vivo or in vivo against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation in vivo and ex vivo, which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.

摘要

为了制定对抗细菌生物膜的最佳策略,在这篇综述中,我们更新了关于生物膜形成及其对抗生素耐药性这一日益严重问题的最新知识,这促使人们寻找新的策略来应对这一并发症。基于最近的发现,噬菌体在预防和消除与生物膜相关的感染中的作用得到了强调。已经比较了单独噬菌体或噬菌体鸡尾酒在体外、离体和体内生物膜处理模型中的作用。在体外或体内联合使用噬菌体和抗生素证实了这些药物协同作用改善生物膜去除的早期报道。此外,关于噬菌体衍生溶素在体外、离体或体内针对与生物膜相关的感染的应用的研究令人鼓舞。噬菌体和抗生素联合使用的策略似乎与溶素和抗生素的联合使用不同。这些发现表明,噬菌体和溶素单独或与抗生素联合使用可能是对抗体内和体外生物膜形成的有效武器,这可能有助于制定对抗细菌感染的新策略。这些发现证明在预防和破坏尿路感染、骨科植入物相关感染、牙周炎和种植体周围感染中发生的生物膜方面是相关的。总之,似乎消除生物膜的最有效策略涉及噬菌体或溶素与抗生素联合使用,但它们的最佳给药方案需要进一步研究。

相似文献

1
Bacteriophages and Lysins in Biofilm Control.噬菌体和生物膜控制中的溶菌素
Virol Sin. 2020 Apr;35(2):125-133. doi: 10.1007/s12250-019-00192-3. Epub 2020 Mar 3.
5
The use of bacteriophages to biocontrol oral biofilms.利用噬菌体对口腔生物膜进行生物防治。
J Biotechnol. 2017 May 20;250:29-44. doi: 10.1016/j.jbiotec.2017.01.002. Epub 2017 Jan 17.

引用本文的文献

本文引用的文献

1
Managing urinary tract infections through phage therapy: a novel approach.通过噬菌体疗法治疗尿路感染:一种新方法。
Folia Microbiol (Praha). 2020 Apr;65(2):217-231. doi: 10.1007/s12223-019-00750-y. Epub 2019 Sep 7.
3
Phage therapy: Current status and perspectives.噬菌体疗法:现状与展望。
Med Res Rev. 2020 Jan;40(1):459-463. doi: 10.1002/med.21593. Epub 2019 May 7.
4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验